phone icon  Toll Free : +1-800-792-5285 | (UK) : + 44-845-528-1300
Allied Market Research

0
Shopping Cart is Empty..
$ 0
CART  yellow arrow
 

Metacycline is a broad spectrum semisynthetic antibiotic that belongs to tetracycline drug class. Esarondil, physiomycine, lysocline, and rotilen are some of the brand names of the antibiotic. Metacycline inhibits protein synthesis and hence cell growth by preventing the binding of aminoacyl transfer RNA to the m-RNA-ribosome complex in the ribosome 30S subunit. The antibiotic is administered in the form of oral tablets.

The wide spectrum of antimicrobial action with the use of metacyclin makes it an active component against gram-positive and gram-negative bacteria. The increase in the incidence of diseases such as rickettsiae, pneumonia, sinusitis, trench fever, and typhus increases the demand for metacycline, which in turn boosts the market growth. Nevertheless, the adverse effects associated with the use of metacycline such as hepatotoxicity, diarrhea, nausea, enterocolitis, and diarrhea hamper the market growth. In addition, the rise in the number of antibiotic resistant organisms and availability of substitutes such as miciclin, monatrex, and muvito also limit the growth of the market.

The global metacycline market is segmented based on application and geography. Based on therapeutics, it is classified into chronic bronchitis, rickettsial infections, pneumonia, trench fever, typhus, Q fever, sinusitis, and others. By geography, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Comprehensive competitive analysis and profiles of major market players such as Merck, Boc Sciences, Manus Aktteva Biopharma LLP, Cayman Chemical, Hycultec GmbH, Abcam plc, Santa Cruz Biotechnology, Inc., Hlzel Biotech, Changzhou Pharmaceutical Factory, and The ND Pharma & Biotech Company are also provided in the report.

Key Benefits

  • This report provides an extensive analysis of the current and emerging market trends and dynamics in the global metacycline market.
  • This report entails the detailed quantitative analysis of the current market and estimations through 2017-2023, which assists in identifying the prevailing market opportunities.
  • The projections in this report are made by analyzing the current trends and future market potential from 2017 to 2023 in terms of value.
  • Competitive intelligence (of leading manufacturers and distributors of disposable gloves) helps understand the competitive scenario across the geographies
  • An in-depth analysis of current research and clinical developments within the market is provided with key market dynamic factors that help understand the behavior of the market.

Metacycline Market Key Segments:

By Therapeutics

  • Chronic bronchitis
  • Rickettsial infections
  • Pneumonia
  • Trench fever
  • Typhus
  • Q fever
  • Sinusitis
  • Others

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest ofEurope
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA

Enquiry About Report

Let us know more about your research need and we will customize an offer exclusively for you!

Please input above shown text into input box
or click refresh

* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com

Chapter: 1INTRODUCTION

1.1.REPORT DESCRIPTION
1.2.KEY BENEFITS
1.3.KEY MARKET SEGMENTS
1.4.RESEARCH METHODOLOGY

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools & models

Chapter: 2EXECUTIVE SUMMARY

2.1.CXO PERSPECTIVE

Chapter: 3MARKET OVERVIEW

3.1.MARKET DEFINITION AND SCOPE
3.2.KEY FINDINGS

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.MARKET SHARE ANALYSIS, 2016
3.4.PORTER’S FIVE FORCES ANALYSIS

3.4.1.MARKET DYNAMICS
3.4.2.Drivers
3.4.3.Restraints
3.4.4.Opportunities

Chapter: 4METACYCLINE MARKET, BY THERAPEUTICS

4.1.OVERVIEW

4.1.1.Market size and forecast

4.2.CHRONIC BRONCHITIS

4.2.1.Key market trends
4.2.2.Growth factors and opportunities
4.2.3.Market size and forecast

4.3.RICKETTSIAL INFECTIONS

4.3.1.Key market trends
4.3.2.Growth factors and opportunities
4.3.3.Market size and forecast

4.4.PNEUMONIA

4.4.1.Key market trends
4.4.2.Growth factors and opportunities
4.4.3.Market size and forecast

4.5.TRENCH FEVER

4.5.1.Key market trends
4.5.2.Growth factors and opportunities
4.5.3.Market size and forecast

4.6.TYPHUS

4.6.1.Key market trends
4.6.2.Growth factors and opportunities
4.6.3.Market size and forecast

4.7.Q FEVER

4.7.1.Key market trends
4.7.2.Growth factors and opportunities
4.7.3.Market size and forecast

4.8.SINUSITIS

4.8.1.Key market trends
4.8.2.Growth factors and opportunities
4.8.3.Market size and forecast

4.9.OTHERS

4.9.1.Key market trends
4.9.2.Growth factors and opportunities
4.9.3.Market size and forecast

Chapter: 5METACYCLINE MARKET, BY GEOGRAPHY

5.1.OVERVIEW
5.2.NORTH AMERICA

5.2.1.Key market trends
5.2.2.Key growth factors and opportunities
5.2.3.Market size and forecast

5.2.3.1.U.S. market size and forecast
5.2.3.2.Canada market size and forecast
5.2.3.3.Mexico market size and forecast

5.2.4.North America Metacycline Market by Therapeutics

5.3.EUROPE

5.3.1.Key market trends
5.3.2.Key growth factors and opportunities
5.3.3.Market size and forecast

5.3.3.1.Germany market size and forecast
5.3.3.2.France market size and forecast
5.3.3.3.UK market size and forecast
5.3.3.4.Italy market size and forecast
5.3.3.5.Spain market size and forecast
5.3.3.6.Rest of Europe market size and forecast

5.3.4.Europe Metacycline Market by Therapeutics

5.4.ASIA-PACIFIC

5.4.1.Key market trends
5.4.2.Key growth factors and opportunities
5.4.3.Market size and forecast

5.4.3.1.Japan market size and forecast
5.4.3.2.China market size and forecast
5.4.3.3.Australia market size and forecast
5.4.3.4.India market size and forecast
5.4.3.5.South Korea market size and forecast
5.4.3.6.Taiwan market size and forecast
5.4.3.7.Rest of Asia-Pacific market size and forecast

5.4.4.Asia-Pacific Metacycline Market by Therapeutics

5.5.LAMEA

5.5.1.Key market trends
5.5.2.Key growth factors and opportunities
5.5.3.Market size and forecast

5.5.3.1.Brazil market size and forecast
5.5.3.2.Turkey market size and forecast
5.5.3.3.Saudi Arabia market size and forecast
5.5.3.4.South Africa market size and forecast
5.5.3.5.Rest of LAMEA market size and forecast

5.5.4.LAMEA Metacycline Market by Therapeutics

Chapter: 6COMPANY PROFILES

6.1.MERCK

6.1.1.Operating business segments
6.1.2.Business performance
6.1.3.Key strategic moves and developments

6.2.BOC SCIENCES

6.2.1.Operating business segments
6.2.2.Business performance
6.2.3.Key strategic moves and developments

6.3.MANUS AKTTEVA BIOPHARMA LLP

6.3.1.Operating business segments
6.3.2.Business performance
6.3.3.Key strategic moves and developments

6.4.CAYMAN CHEMICAL

6.4.1.Operating business segments
6.4.2.Business performance
6.4.3.Key strategic moves and developments

6.5.HYCULTEC GMBH

6.5.1.Operating business segments
6.5.2.Business performance
6.5.3.Key strategic moves and developments

6.6.ABCAM PLC

6.6.1.Operating business segments
6.6.2.Business performance
6.6.3.Key strategic moves and developments

6.7.SANTA CRUZ BIOTECHNOLOGY, INC.

6.7.1.Operating business segments
6.7.2.Business performance
6.7.3.Key strategic moves and developments

6.8.HÖLZEL BIOTECH

6.8.1.Operating business segments
6.8.2.Business performance
6.8.3.Key strategic moves and developments

6.9.CHANGZHOU PHARMACEUTICAL FACTORY

6.9.1.Operating business segments
6.9.2.Business performance
6.9.3.Key strategic moves and developments

6.10.ND PHARMA & BIOTECH COMPANY

6.10.1.Operating business segments
6.10.2.Business performance
6.10.3.Key strategic moves and developments
With collective industry experience of about 200 years of its analysts and experts, Allied Market Research (AMR) encompasses most infallible research methodology for its market intelligence and industry analysis. We do not only engrave the deepest levels of markets but also sneak through its slimmest details for the purpose of our market estimates and forecasts. Our approach helps in building greater market consensus view for size, shape and industry trends within each industry segment. We carefully factor in industry trends and real developments for identifying key growth factors and future course of the market. Our research proceeds are the resultant of high quality data, expert views and analysis and high value independent opinions. Our research process is designed to deliver balanced view of the global markets and allow stakeholders to make informed decisions.

We offer our clients exhaustive research and analysis based on wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics and regional intelligence. Our in-house industry experts play instrumental role in designing analytic tools and models, tailored to the requirements of particular industry segment. These analytical tools and models sanitize the data & statistics and enhance the accuracy of our recommendations and advice. With AMR’s calibrated research process and 360` degree data-evaluation methodology, our clients are assured of receiving:

  • Consistent, valuable, robust and actionable data & analysis that can easily be referenced for strategic business planning
  • Technologically sophisticated and reliable insights through well audited and veracious research methodology
  • Sovereign research proceeds that present a tangible depiction of marketplace


With a strong methodology we are, therefore, confident that our research and analysis are most reliable and guarantees sound business planning.

Secondary research
We refer a broad array of industry sources for our secondary, which typically include; however, not limited to: Company SEC filings, annual reports, company websites, broker & financial reports and investor presentations for competitive scenario and shape of the industry

  • Patent and regulatory databases for understanding of technical & legal developments
  • Scientific and technical writings for product information and related preemptions
  • Regional government and statistical databases for macro analysis
  • Authentic new articles, web-casts and other related releases for market evaluation
  • Internal and external proprietary databases, key market indicators and relevant press releases for market estimates and forecast


Primary research
Our primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks and face-to-face interactions. We are also in professional corporate relations with various companies that allow us greater flexibility for reaching out industry participants and commentators for interviews and discussions, fulfilling following functions:

  • Validates and improves the data quality and strengthens research proceeds
  • Further develops analyst team’s market understanding and expertise
  • Supplies authentic information about market size, share, growth and forecasts


Our primary research interview and discussion panels are typically composed of most experienced industry members. These participants include; however, not limited to:

  • Chief executives and VPs of leading corporations specific to industry
  • Product and sales managers or country heads; channel partners and top level distributors; banking, investments and valuation experts Key opinion leaders (KOLs)


Analyst tools and models
AMR has developed set of analyst tools and data models to supplement and expedite the analysis process. Corresponding to markets, where there is significant lack of information and estimates, AMR’s team of experts and analyst develop specific analyst tools and industry models to translate qualitative and quantitative industry indicators into exact industry estimates. These models also allow analysts to examine the prospects and opportunities prevailing in the market to accurately forecast the course of the market.
License Type
Data Pack
Single User PDF
Five User Online/PDF
Enterprise Online/PDF
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Restricted to one authorized user

Limited to 5 authorized users


Unlimited within company / enterprise
Printing
One Print only

One Print only
Up to Five Copies
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
Speak with analyst
connect
Did you miss anything?
To add more
request

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

 

Featured Readings

Further Readings

 

Get fresh content delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

About
US
Find
HELP
Consulting &
CUSTOM STUDIES
Our
PRODUCTS
Our
SERVICES
Press
MEDIA
STAY WITH US

fb blogger linkedin Gplus twitter Youtube Rss

WE ACCEPT


weAccept